Collapsible/expandable electrode leads

• US 7,177,702 B2
• Filed: 03/12/2004
• Issued: 02/13/2007
• Est. Priority Date: 03/12/2004
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Scimed Life Systems Incorporated (Boston Scientific Corporation)
• Inventors: Garabedian, Robert J., Wallace, Michael P., Leynov, Alex
• Primary Examiner(s): Bockelman; Mark
• Application Number:
  US10/799,270
• Publication Number:
  US 20050203602A1
• Time in Patent Office: 1,068 Days
• Field of Search: 607/116, 607/117, 607/122, 607/123, 607/128, 607/129, 607/30, 600/386
• US Class Current: 607/117
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/0558 Anchoring or fixation means therefor

Abstract

A medical lead and method of treating a patient are provided. The medical lead comprises an electrically insulative membrane, a resilient spring element associated with the insulative membrane, and at least one electrode associated with the insulative membrane. The spring layer is configured to urge that insulative membrane into an expanded geometry. The medical lead is configured to be collapsed into a compact form for percutaneous delivery into the patient, thereby obviating the need to perform an invasive surgical procedure on the patient. The patient can be treated by placing the medical lead into a collapsed state by applying a compressive force to the medical lead, percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated, and placing the medical lead into an expanded state by releasing the compressive force.

Claims

1. A medical lead, comprising:

an electrically insulative membrane having a first stiffness and tissue-contacting outer surface;

a resilient skeletal spring layer disposed on the tissue-contacting outer surface of the insulative membrane, wherein the spring layer has a second stiffness greater than the first stiffness; and

at least one electrode associated with the insulative membrane.

2. The medical lead of claim 1, wherein the insulative membrane is flaccid.

3. The medical lead of claim 1, wherein the insulative membrane is paddle-shaped.

4. The medical lead of claim 1, wherein the insulative membrane is tube-shaped.

5. The medical lead of claim 1, wherein the spring layer is configured to urge the insulative membrane into a planar geometry.

6. The medical lead of claim 1, wherein the spring layer is configured to urge the insulative membrane into a curviplanar geometry.

7. The medical lead of claim 1, wherein the spring layer wraps around onto itself.

8. The medical lead of claim 1, wherein the insulative membrane has two outer opposing surfaces, the spring layer is associated with one of the two surfaces, and the at least one electrode is associated with the other of the two surfaces.

9. The medical lead of claim 1, wherein the insulative membrane has two external opposing surfaces, and the spring layer and the at least electrode are associated with the same one of the two surfaces.

10. The medical lead of claim 1, wherein the insulative membrane, spring layer, and at least one electrode form a body that is configured to inhibit tissue growth.

11. The medical lead of claim 1, wherein the insulative membrane, spring layer, and at least one electrode form a body that is configured to be collapsed into a compact form for percutaneous delivery into a patient.

12. The medical lead of claim 1, wherein the insulative membrane, spring layer, and at least one electrode form an expanded body that is sized to fit within the epidural space of a patient.

13. A method of treating a patient, comprising:

placing the medical lead of claim 1, into a collapsed state by applying a compressive force to the medical lead;

percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated; and

placing the medical lead into an expanded state by releasing the compressive force, whereby the resilient spring layer facilitates expansion of the medical lead.

14. The method of claim 13, further comprising stimulating the tissue with the medical lead.

15. The method of claim 13, wherein the tissue is spinal cord tissue.

16. A medical lead, comprising:

an electrically insulative membrane having a longitudinal axis and a tissue-contacting surface;

a resilient spring element associated with the tissue-contacting surface of the insulative membrane, wherein the spring element comprises a main segment that extends along the longitudinal axis and a plurality of secondary segments that branch off of the main segment; and

at least one electrode associated with the insulative membrane.

17. The medical lead of claim 16, wherein the insulative membrane is flaccid.

18. The medical lead of claim 16, wherein the insulative membrane is paddle-shaped.

19. The medical lead of claim 16, wherein the insulative membrane is tube-shaped.

20. The medical lead of claim 16, wherein the spring element is configured to urge the insulative membrane into a planar geometry.

21. The medical lead of claim 16, wherein the spring element is configured to urge the insulative membrane into a curviplanar geometry.

22. The medical lead of claim 16, wherein the insulative membrane has two outer opposing surfaces, the spring element is associated with one of the two surfaces, and the at least one electrode is associated with the other of the two surfaces.

23. The medical lead of claim 16, wherein the insulative membrane has two outer opposing surfaces, and the spring layer and the at least electrode are associated with the same one of the two surfaces.

24. The medical lead of claim 16, wherein the secondary segments bilaterally branch off of the main segment.

25. The medical lead of claim 16, wherein the secondary segments unilaterally branch off of the main segment.

26. The medical lead of claim 16, wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to inhibit tissue growth.

27. The medical lead of claim 16, wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to be collapsed into a compact form for percutaneous delivery into a patient.

28. The medical lead of claim 16, wherein the insulative membrane, spring element, and at least one electrode form an expanded body that is sized to fit within the epidural space of a patient.

29. A method of treating a patient, comprising:

placing the medical lead of claim 16 into a collapsed state by applying a compressive force to the medical lead;

percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated; and

placing the medical lead into an expanded state by releasing the compressive force, whereby the resilient spring element facilitates expansion of the medical lead.

30. The method of claim 29, further comprising stimulating the tissue with the medical lead.

31. The method of claim 29, wherein the tissue is spinal cord tissue.

32. The medical lead of claim 16, wherein the insulative membrane has an outer surface, and the spring element is in contact with the outer surface of the insulative membrane.

33. The medical lead of claim 16, wherein the spring element is in a laminar relationship with the insulative membrane.

34. A medical lead, comprising:

an electrically insulative body having a tissue-contacting planar region;

a resilient skeletal spring element in contact with the tissue-contacting planar region of the insulative body; and

at least one electrode associated with the planar region.

35. The medical lead of claim 34, wherein the planar region of the insulative body is flaccid.

36. The medical lead of claim 34, wherein the planar region of the insulative body is paddle-shaped.

37. The medical lead of claim 34, wherein the planar region of the insulative body is tube-shaped.

38. The medical lead of claim 34, wherein the planar region of the insulative body has two outer opposing surfaces, the spring element is associated with one of the two surfaces, and the at least one electrode is associated with the other of the two surfaces.

39. The medical lead of claim 34, wherein the planar region of the insulative body has two outer opposing surfaces, and the spring element and the at least electrode are associated with the same one of the two surfaces.

40. The medical lead of claim 34, wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to inhibit tissue growth.

41. The medical lead of claim 34, wherein the insulative membrane, spring element, and at least one electrode form a body that is configured to be collapsed into a compact form for percutaneous delivery into a patient.

42. The medical lead of claim 34, wherein the insulative membrane, spring element, and at least one electrode form an expanded body that is sized to fit within the epidural space of a patient.

43. A method of treating a patient, comprising:

placing the medical lead of claim 34 into a collapsed state by applying a compressive force to the medical lead;

percutaneously delivering the collapsed medical lead into the patient adjacent tissue to be treated; and

placing the medical lead into an expanded state by releasing the compressive force, whereby the resilient spring element facilitates expansion of the medical lead.

44. The method of claim 43, further comprising stimulating the tissue with the medical lead.

45. The method of claim 43, wherein the tissue is spinal cord tissue.

46. The medical lead of claim 34, wherein the planar region of the insulative body has an outer surface, and the spring element is in contact with the outer surface of the planar region.

47. The medical lead of claim 34, wherein the spring element is in a laminar relationship with the insulative body.